Peripheral Vascular Devices Market Is Projected To Reach A Valuation US$ 16.83 Billion By The End Of 2033

Published April 22, 2023

The peripheral vascular devices market refers to the medical devices and instruments that are used to diagnose and treat diseases of the blood vessels outside the heart, such as the arteries and veins of the arms, legs, and other parts of the body. These devices include stents, catheters, angioplasty balloons, vascular grafts, atherectomy devices, and other minimally invasive devices. The market for peripheral vascular devices is driven by several factors, including the increasing prevalence of peripheral artery disease (PAD) and other vascular diseases, as well as the growing demand for minimally invasive procedures. Additionally, advancements in technology and the development of new and innovative devices are also contributing to the growth of the market.

The market is segmented by product type, application, end-user, and geography. Some of the key players in the market include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Medtronic plc, and Terumo Corporation, among others.

The global peripheral vascular devices market is expected to continue to grow in the coming years, as the prevalence of vascular diseases continues to increase, particularly in aging populations. Additionally, the ongoing development of new and innovative devices is expected to further drive market growth.

Get a Free Sample PDF of this Research Report

Key findings of the Peripheral Vascular Devices market study:

  • The report provides a present market outlook on Peripheral Vascular Devices. Additionally, the Peripheral Vascular Devices market share is anticipated to grow with a CAGR of 4.5% in the forecast period.
  • Regional breakdown of the Peripheral Vascular Devices market based on predefined taxonomy.
  • Innovative manufacturing processes implemented by Peripheral Vascular Devices vendors in detail.
  • Region-wise and country-wise fragmentation of the Peripheral Vascular Devices market to grasp the revenue, and growth outlook in these areas.
  • Changing preferences among consumers across various regions and countries.
  • Factors (Positive and Negative) impacting the growth of the global Peripheral Vascular Devices market.
  • Peripheral Vascular Devices price, market share, and Trends forecast for assessment period 2023-2033

What is the Demand Outlook for Peripheral Vascular Intervention Treatment Procedures in the United States?

The demand outlook for peripheral vascular intervention treatment procedures in the United States is expected to remain strong in the coming years. This is due to several factors, including an aging population, increasing prevalence of peripheral artery disease (PAD) and other vascular diseases, and advancements in minimally invasive procedures. The US peripheral vascular intervention market is expected to grow at a CAGR of 6.1% during the forecast period of 2018-2023. The report attributes this growth to factors such as the increasing prevalence of PAD, the availability of favorable reimbursement policies, and the development of technologically advanced devices.

In addition, the COVID-19 pandemic has increased the demand for minimally invasive procedures as hospitals and healthcare facilities seek to reduce the risk of infection and conserve resources. This has led to an increased focus on outpatient procedures, including those for peripheral vascular intervention.

Overall, the demand outlook for peripheral vascular intervention treatment procedures in the United States is expected to remain positive in the coming years, driven by demographic and technological factors, as well as ongoing trends in healthcare delivery.

Competitive landscape analysis

Key competitors in the peripheral vascular devices market are creating sophisticated gadgets in order to enhance and retain their market position. Mergers, acquisitions, collaborations, new product innovations, and improving local supply management systems are some of the marketing strategies used by market participants.

  • In September 2021, Abbott announced the purchase of Walk Vascular, an LLC that manufactures medical equipment that include a minimally-invasive mechanical aspiration peripheral venous thrombectomy device for the removal of peripheral blood clots. Abbott’s current endovascular product portfolio includes Walk Vascular’s peripheral thrombectomy systems. Abbott’s peripheral vascular devices and accessories were expanded as a result of the collaboration.
  • Cardio Flow, Inc., manufacturer of minimally-invasive peripheral vascular devices for the treatment of peripheral artery disease, announced in June 2022 that the FreedomFlow Peripheral Guidewire has received FDA approval.

Some of the leading companies operating in the market are :

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cordis Corporation
  • iVascular S.L.U
  • Medtronic PLC
  • Terumo Corporation

 What insights does the Peripheral Vascular Devices report provide to the readers?

  • Peripheral Vascular Devices fragmentation on the basis of product type, end use, and region.
  • Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
  • Collaborations, R&D projects, acquisitions, and product launches of each Peripheral Vascular Devices
  • Various regulations imposed by the governments on the consumption of Peripheral Vascular Devices in detail.

Key Segments of Peripheral Vascular Devices Industry Research

  • By Type :
    • Angioplasty Stents
    • Angioplasty Balloon Catheters
    • Endovascular Aneurysm Repair (EVAR) Stent Grafts
    • Plaque Modification Devices
    • Hemodynamic Flow Alteration Devices
    • Inferior Vena Cava Filters
  • By Indication :
    • Target Artery Instabilities (TAIs)
    • Access Artery Injuries (AAIs)
    • Peripheral Arterial Diseases
    • Arteriovenous Fistulas
    • Peripheral Aneurysms
  • By End User :
    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Catheterization Labs
  • By Region :
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

 For in-depth competitive analysis, Buy Now –


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583


This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on


Xherald is passionate about offering extensive coverage of global business news. Dedicated to creating every participant's notification, it reaches its own reader. Daily our experts offer fresh relevant information regarding what is actually occurring in Markets as well as Business. Our headlines are actually swiftly paced and extensive. Our distributor directory connects you with brand new products or services and its market situation from the most effective companies around the planet. Xherald is driven by its 500+ contributors coming from around the world. Xherald provides local as well as global market intelligence information coverage in sectors ranging from healthcare, IOT, chemicals and 17 more sectors. Our updates are quickly paced and detailed. The news we present is actually a mix of authentic content, community contributions and curated headlines announcements. All of the updates our company supplies must pass a strict criterion of genuineness, relevance and significance to our readers.